WO2022036303A1 - Virus/biohazard indicating disposable face mask - Google Patents

Virus/biohazard indicating disposable face mask Download PDF

Info

Publication number
WO2022036303A1
WO2022036303A1 PCT/US2021/046079 US2021046079W WO2022036303A1 WO 2022036303 A1 WO2022036303 A1 WO 2022036303A1 US 2021046079 W US2021046079 W US 2021046079W WO 2022036303 A1 WO2022036303 A1 WO 2022036303A1
Authority
WO
WIPO (PCT)
Prior art keywords
face mask
disease
infectious disease
virus
group
Prior art date
Application number
PCT/US2021/046079
Other languages
French (fr)
Inventor
Keith H. Taylor
Original Assignee
Taylor Keith H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taylor Keith H filed Critical Taylor Keith H
Publication of WO2022036303A1 publication Critical patent/WO2022036303A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A62—LIFE-SAVING; FIRE-FIGHTING
    • A62B—DEVICES, APPARATUS OR METHODS FOR LIFE-SAVING
    • A62B18/00—Breathing masks or helmets, e.g. affording protection against chemical agents or for use at high altitudes or incorporating a pump or compressor for reducing the inhalation effort
    • A62B18/08—Component parts for gas-masks or gas-helmets, e.g. windows, straps, speech transmitters, signal-devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
    • A61B5/082—Evaluation by breath analysis, e.g. determination of the chemical composition of exhaled breath
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
    • A61B5/6802—Sensor mounted on worn items
    • A61B5/6803—Head-worn items, e.g. helmets, masks, headphones or goggles
    • A—HUMAN NECESSITIES
    • A62—LIFE-SAVING; FIRE-FIGHTING
    • A62B—DEVICES, APPARATUS OR METHODS FOR LIFE-SAVING
    • A62B9/00—Component parts for respiratory or breathing apparatus
    • A62B9/006—Indicators or warning devices, e.g. of low pressure, contamination
    • A—HUMAN NECESSITIES
    • A41—WEARING APPAREL
    • A41D—OUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
    • A41D13/00—Professional, industrial or sporting protective garments, e.g. surgeons' gowns or garments protecting against blows or punches
    • A41D13/05—Professional, industrial or sporting protective garments, e.g. surgeons' gowns or garments protecting against blows or punches protecting only a particular body part
    • A41D13/11—Protective face masks, e.g. for surgical use, or for use in foul atmospheres
    • A—HUMAN NECESSITIES
    • A62—LIFE-SAVING; FIRE-FIGHTING
    • A62B—DEVICES, APPARATUS OR METHODS FOR LIFE-SAVING
    • A62B23/00—Filters for breathing-protection purposes
    • A62B23/02—Filters for breathing-protection purposes for respirators
    • A62B23/025—Filters for breathing-protection purposes for respirators the filter having substantially the shape of a mask

Definitions

  • the present invention relates to compositions and methods for detecting viruses and other biohazards. More specifically, the present invention relates to face masks that indicate the presence of a virus or biohazard.
  • Infectious diseases are diseases caused by pathogenic microorganisms such as bacteria, viruses, parasites, or fungi that can be spread from person to person, either directly or indirectly.
  • Coronavirus Disease 2019 is a severe acute respiratory syndrome (SARS) coronavirus 2 that originated in 2019 in Wuhan, China, and has quickly spread around the world.
  • SARS severe acute respiratory syndrome
  • Symptoms include fever, cough, shortness of breath, loss of smell and taste, and it is very similar to influenza. Due to the presence of infected asymptomatic individuals, it is hard to tell who is actually infected. While many people recover and have mild symptoms, those who are older and have comorbidities are at risk of serious illness or death. While tests are available to identify COVID-19, there is a delay in test results due to the overwhelming request for tests and individuals could be infected and continue spreading the virus.
  • the present invention provides for a face mask, including a body and at least one securing mechanism operatively attached thereto, and a used indicator mechanism for indicating that the face mask is used and an infectious disease detection mechanism for indicating if the user wearing the face mask has an infectious disease operatively integrated into the body.
  • the present invention provides for a method of indicating whether a face mask is used, by a user actuating a used indicator mechanism on the face mask, wearing the face mask, and the used indicator mechanism indicating that the face mask is used.
  • the present invention also provides for a method of indicating whether a user has an infectious disease, by a user actuating an infectious disease mechanism on a face mask, wearing the face mask, and the infectious disease mechanism indicating that the user has an infectious disease by changing from a first color to a second color.
  • FIGURE 1 is a top view of a face mask
  • FIGURE 2 is a top view of a face mask with a used indicator mechanism/virus detection mechanism activated
  • FIGURE 3 is a back view of the face mask.
  • the present invention provides for a face mask 10, shown in FIGURES 1 and 2, including a body 12 and at least one securing mechanism 14 operatively attached thereto, and a used indicator mechanism 16 for indicating that the face mask 10 is used and an infectious disease detection mechanism 18 for indicating if the user wearing the face mask 10 has an infectious disease operatively integrated into the body 12.
  • the body 12 can be made of any suitable material, such as any cloth, cotton, nylon, or filter material and can include multiple layers.
  • the body 12 can be in different sizes to fit children (i.e. child sized) or adult (i.e. adult sized) faces.
  • the body 12 can include a pocket 20 for filters on an inner surface 24 (shown in FIGURE 3).
  • the face mask 10 is secured on an user’s head with the securing mechanism 14 (such as elastic ear loops attached at opposite ends of the body 12 shown in FIGURES 1 and 2).
  • the securing mechanism 14 such as elastic ear loops attached at opposite ends of the body 12 shown in FIGURES 1 and 2).
  • Other designs can include loops or ties that fit around the head, ties that tie around the ears, or combinations of loops and ties.
  • the used indicator mechanism 16 indicates whether the face mask 10 has been used and whether it should be disposed of.
  • the used indicator mechanism 16 can emit an odor after 24 hours of use of the face mask 10 (or other appropriate predetermined periods of time, such as 1 hour, 5 hours, 10 hours, 15 hours, or 20 hours). If the face mask 10 smells, this is an indication to the user not to put the face mask 10 on because it is used, or to take it off because it has been used too long.
  • the used indicator mechanism 16 can alternatively, or in addition, be a color change mechanism wherein the body 12 changes from a first unused color (FIGURE 1 ) to a second used color (FIGURE 2).
  • the color change mechanism can be a solid color or a colored design.
  • the used indicator mechanism 16 can be passively activated (such as the user putting on the face mask 10) or actively activated (such as by the user coughing into the face mask 10, clicking an actuator on the face mask 10, opening packaging containing the face mask 10, peeling off a layer protecting the used indicator mechanism 16, or any other suitable method).
  • the used indicator mechanism 16 can be integrated into the body 12, either the entire body 12 or a portion of the body 12, and be on an outer surface 22 of the body, an inner surface 24 of the body, or both.
  • the infectious disease detection mechanism 18 indicates whether the user has an infectious disease.
  • the infectious disease detection mechanism 18 can include any suitable detection mechanism to indicate the presence of disease, such as antibody detection, DNA detection, RNA detection, or protein detection.
  • the infectious disease detection mechanism 18 includes a color change mechanism wherein the body 12 changes from a first color (FIGURE 1 ) indicating no disease to a second color (FIGURE 2) indicating the presence of disease.
  • the color change mechanism can be a solid color or a colored design. Any distinguishable colors can be used, such as, but not limited to, red, orange, yellow, green, blue, purple, grey, black, white. Preferably, the color is different than that used for the used indicator mechanism 16.
  • the infectious disease detection mechanism 18 can be passively activated (such as the user putting on the face mask 10) or actively activated (such as by the user coughing into the face mask 10, clicking an actuator on the face mask 10, opening packaging containing the face mask 10, peeling off a layer protecting the infectious disease detection mechanism 18 before use, or any other suitable method).
  • the infectious disease detection mechanism 18 can be integrated into the body 12, either the entire body 12 or a portion of the body 12, and can be on a separate portion of the body 12 than the used indicator mechanism 16.
  • the infectious disease detection mechanism 18 can be on an outer surface 22 of the body 12 (visible to others, which is useful to let other know of exposure to disease), an inner surface 24 of the body 12 (the side against a user’s face), or both.
  • the infectious disease detection mechanism 18 can also be integrated on a disposable filter insert inside the pocket 20 in the body 12.
  • the infectious disease detection mechanism 18 can indicate the user’s disease status in real time and indicate whether they should seek medical attention.
  • the infectious disease can include a viral, protozoan, or bacterial disease such as most preferably influenza, measles, or COVID-19, or any of AIDS, amebiasis, anaplasmosis, anthrax, antibiotic resistance, avian influenza, babesiosis, botulism, brucellosis, Campylobacter, cat scratch disease, chickenpox, chikungunya, chlamydia trachomatis, cholera, Clostridium perfringens, conjunctivitis, crusted scabies, cryptosporidiosis, cyclospora, dengue fever, diphtheria, ebola virus disease, E.
  • a viral, protozoan, or bacterial disease such as most preferably influenza, measles, or COVID-19, or any of AIDS, amebiasis, anaplasmosis, anthrax, antibiotic resistance, avian influenza, babesiosis
  • coli eastern equine encephalitis (EEE), enterovirus 68, fifth disease, genital herpes, genital warts, giardia, gonorrhea, group A Streptococcus, Guillain-Barre syndrome, Hand, Foot & Mouth Disease, Hansen's disease, hantavirus, lice, hepatitis A, hepatitis B, hepatitis C, herpes, herpes B virus, Hib disease, histoplasmosis, HIV, HPV (Human Papillomavirus), impetigo, Kawasaki syndrome, legionellosis, leprosy, leptospirosis, listeriosis, lyme disease, lymphocytic choriomeningitis (LCMV), malaria, Marburg virus, meningitis, meningococcal disease, MERS (Middle East Respiratory Illness), monkeypox, mononucleosis, MRSA,
  • the present invention provides for a method of indicating whether a face mask 10 is used, by a user actuating a used indicator mechanism 16 on the face mask 10, wearing the face mask 10, and the used indicator mechanism 16 indicating that the face mask 10 is used.
  • the used indicator mechanism 16 indicates that the face mask 10 is used through an odor and/or a color change as described above after a set/predetermined amount of time of use, and the user can then dispose of the face mask 10.
  • the present invention also provides for a method of indicating whether a user has an infectious disease, by a user actuating an infectious disease mechanism 18 on a face mask 10, wearing the face mask 10, and the infectious disease mechanism 18 indicating that the user has an infectious disease by changing from a first color to a second color.
  • the user can either indicate to others that they are disease-free or that they need to seek medical attention or quarantine themselves.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Management (AREA)
  • Biophysics (AREA)
  • Business, Economics & Management (AREA)
  • Physiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A face mask, including a body and at least one securing mechanism operatively attached thereto, and a used indicator mechanism for indicating that the face mask is used and an infectious disease detection mechanism for indicating if the user wearing the face mask has an infectious disease operatively integrated into the body. A method of indicating whether a face mask is used, by a user actuating a used indicator mechanism on the face mask, wearing the face mask, and the used indicator mechanism indicating that the face mask is used. A method of indicating whether a user has an infectious disease, by a user actuating an infectious disease mechanism on a face mask, wearing the face mask, and the infectious disease mechanism indicating that the user has an infectious disease by changing from a first color to a second color.

Description

VIRUS/BIOHAZARD INDICATING DISPOSABLE FACE MASK
BACKGROUND OF THE INVENTION
1. TECHNICAL FIELD
[0001] The present invention relates to compositions and methods for detecting viruses and other biohazards. More specifically, the present invention relates to face masks that indicate the presence of a virus or biohazard.
2. BACKGROUND ART
[0002] Infectious diseases are diseases caused by pathogenic microorganisms such as bacteria, viruses, parasites, or fungi that can be spread from person to person, either directly or indirectly.
[0003] Coronavirus Disease 2019 (COVID-19) is a severe acute respiratory syndrome (SARS) coronavirus 2 that originated in 2019 in Wuhan, China, and has quickly spread around the world. The viral infection is spread from person to person by respiratory droplets. Symptoms include fever, cough, shortness of breath, loss of smell and taste, and it is very similar to influenza. Due to the presence of infected asymptomatic individuals, it is hard to tell who is actually infected. While many people recover and have mild symptoms, those who are older and have comorbidities are at risk of serious illness or death. While tests are available to identify COVID-19, there is a delay in test results due to the overwhelming request for tests and individuals could be infected and continue spreading the virus. Individuals who have been identified as having the virus need to quarantine themselves but cannot do this if they cannot receive test results quickly. Furthermore, even if an individual tests negative, this is not necessarily indicative of their current state of health, which could foster a false consensus that once having undergone testing, it is fine to mix and mingle as they used to with others.
[0004] It has been determined that wearing a face covering or face mask can greatly reduce the spread of COVID-19, especially since one cannot necessarily tell if they are infected. A study by Chu, et al. (The Lancet, June 1 , 2021 ) reports that with the use of face masks, the chance of transmission of COVID-19 was 3% as compared to 17% without a mask. However, many individuals fail to use masks with inconsistent messages from the government, and many use them incorrectly. [0005] Therefore, there remains a need for methods of indicating infected individuals with COVID-19 as well as other infectious diseases, as well as improved face masks.
SUMMARY OF THE INVENTION
[0006] The present invention provides for a face mask, including a body and at least one securing mechanism operatively attached thereto, and a used indicator mechanism for indicating that the face mask is used and an infectious disease detection mechanism for indicating if the user wearing the face mask has an infectious disease operatively integrated into the body.
[0007] The present invention provides for a method of indicating whether a face mask is used, by a user actuating a used indicator mechanism on the face mask, wearing the face mask, and the used indicator mechanism indicating that the face mask is used.
[0008] The present invention also provides for a method of indicating whether a user has an infectious disease, by a user actuating an infectious disease mechanism on a face mask, wearing the face mask, and the infectious disease mechanism indicating that the user has an infectious disease by changing from a first color to a second color.
DESCRIPTION OF THE DRAWINGS
[0009] Other advantages of the present invention are readily appreciated as the same becomes better understood by reference to the following detailed description when considered in connection with the accompanying drawings wherein:
[00010] FIGURE 1 is a top view of a face mask;
[00011] FIGURE 2 is a top view of a face mask with a used indicator mechanism/virus detection mechanism activated; and
[00012] FIGURE 3 is a back view of the face mask.
DETAILED DESCRIPTION OF THE INVENTION
[00013] The present invention provides for a face mask 10, shown in FIGURES 1 and 2, including a body 12 and at least one securing mechanism 14 operatively attached thereto, and a used indicator mechanism 16 for indicating that the face mask 10 is used and an infectious disease detection mechanism 18 for indicating if the user wearing the face mask 10 has an infectious disease operatively integrated into the body 12.
[00014] The body 12 can be made of any suitable material, such as any cloth, cotton, nylon, or filter material and can include multiple layers. The body 12 can be in different sizes to fit children (i.e. child sized) or adult (i.e. adult sized) faces. The body 12 can include a pocket 20 for filters on an inner surface 24 (shown in FIGURE 3).
[00015] The face mask 10 is secured on an user’s head with the securing mechanism 14 (such as elastic ear loops attached at opposite ends of the body 12 shown in FIGURES 1 and 2). Other designs can include loops or ties that fit around the head, ties that tie around the ears, or combinations of loops and ties.
[00016] The used indicator mechanism 16 indicates whether the face mask 10 has been used and whether it should be disposed of. The used indicator mechanism 16 can emit an odor after 24 hours of use of the face mask 10 (or other appropriate predetermined periods of time, such as 1 hour, 5 hours, 10 hours, 15 hours, or 20 hours). If the face mask 10 smells, this is an indication to the user not to put the face mask 10 on because it is used, or to take it off because it has been used too long. The used indicator mechanism 16 can alternatively, or in addition, be a color change mechanism wherein the body 12 changes from a first unused color (FIGURE 1 ) to a second used color (FIGURE 2). The color change mechanism can be a solid color or a colored design. Any distinguishable colors can be used, such as, but not limited to, red, orange, yellow, green, blue, purple, grey, black, white. The used indicator mechanism 16 can be passively activated (such as the user putting on the face mask 10) or actively activated (such as by the user coughing into the face mask 10, clicking an actuator on the face mask 10, opening packaging containing the face mask 10, peeling off a layer protecting the used indicator mechanism 16, or any other suitable method). The used indicator mechanism 16 can be integrated into the body 12, either the entire body 12 or a portion of the body 12, and be on an outer surface 22 of the body, an inner surface 24 of the body, or both.
[00017] The infectious disease detection mechanism 18 indicates whether the user has an infectious disease. The infectious disease detection mechanism 18 can include any suitable detection mechanism to indicate the presence of disease, such as antibody detection, DNA detection, RNA detection, or protein detection.
[00018] The infectious disease detection mechanism 18 includes a color change mechanism wherein the body 12 changes from a first color (FIGURE 1 ) indicating no disease to a second color (FIGURE 2) indicating the presence of disease. The color change mechanism can be a solid color or a colored design. Any distinguishable colors can be used, such as, but not limited to, red, orange, yellow, green, blue, purple, grey, black, white. Preferably, the color is different than that used for the used indicator mechanism 16. The infectious disease detection mechanism 18 can be passively activated (such as the user putting on the face mask 10) or actively activated (such as by the user coughing into the face mask 10, clicking an actuator on the face mask 10, opening packaging containing the face mask 10, peeling off a layer protecting the infectious disease detection mechanism 18 before use, or any other suitable method). The infectious disease detection mechanism 18 can be integrated into the body 12, either the entire body 12 or a portion of the body 12, and can be on a separate portion of the body 12 than the used indicator mechanism 16. The infectious disease detection mechanism 18 can be on an outer surface 22 of the body 12 (visible to others, which is useful to let other know of exposure to disease), an inner surface 24 of the body 12 (the side against a user’s face), or both. The infectious disease detection mechanism 18 can also be integrated on a disposable filter insert inside the pocket 20 in the body 12. The infectious disease detection mechanism 18 can indicate the user’s disease status in real time and indicate whether they should seek medical attention.
[00019] The infectious disease can include a viral, protozoan, or bacterial disease such as most preferably influenza, measles, or COVID-19, or any of AIDS, amebiasis, anaplasmosis, anthrax, antibiotic resistance, avian influenza, babesiosis, botulism, brucellosis, Campylobacter, cat scratch disease, chickenpox, chikungunya, chlamydia trachomatis, cholera, Clostridium perfringens, conjunctivitis, crusted scabies, cryptosporidiosis, cyclospora, dengue fever, diphtheria, ebola virus disease, E. coli, eastern equine encephalitis (EEE), enterovirus 68, fifth disease, genital herpes, genital warts, giardia, gonorrhea, group A Streptococcus, Guillain-Barre syndrome, Hand, Foot & Mouth Disease, Hansen's disease, hantavirus, lice, hepatitis A, hepatitis B, hepatitis C, herpes, herpes B virus, Hib disease, histoplasmosis, HIV, HPV (Human Papillomavirus), impetigo, Kawasaki syndrome, legionellosis, leprosy, leptospirosis, listeriosis, lyme disease, lymphocytic choriomeningitis (LCMV), malaria, Marburg virus, meningitis, meningococcal disease, MERS (Middle East Respiratory Illness), monkeypox, mononucleosis, MRSA, mumps, mycoplasma pneumoniae, neisseria meningitis, norovirus, Orf Virus (Sore Mouth), pelvic inflammatory disease (PID), PEP, pertussis, pink eye, plague, pneumococcal disease, powassan virus, psittacosis, Q fever, rabies, raccoon roundworm, rat bite fever, Reye’s Syndrome, Rickettsialpox, ringworm, rubella, salmonella, scabies, scarlet fever, shigella, shingles, smallpox, strep throat, syphilis, tetanus, toxoplasmosis, trichinosis, trichomoniasis, tuberculosis, tularemia, varicella, vibriosis, viral hemorrhagic fevers (VHF), West Nile virus, whooping cough, yellow fever, yersiniosis, or zika virus. [00020] The present invention provides for a method of indicating whether a face mask 10 is used, by a user actuating a used indicator mechanism 16 on the face mask 10, wearing the face mask 10, and the used indicator mechanism 16 indicating that the face mask 10 is used. Preferably, the used indicator mechanism 16 indicates that the face mask 10 is used through an odor and/or a color change as described above after a set/predetermined amount of time of use, and the user can then dispose of the face mask 10.
[00021] The present invention also provides for a method of indicating whether a user has an infectious disease, by a user actuating an infectious disease mechanism 18 on a face mask 10, wearing the face mask 10, and the infectious disease mechanism 18 indicating that the user has an infectious disease by changing from a first color to a second color. By performing this method, the user can either indicate to others that they are disease-free or that they need to seek medical attention or quarantine themselves.
[00022] Throughout this application, various publications, including United States patents, are referenced by author and year and patents by number. Full citations for the publications are listed below. The disclosures of these publications and patents in their entireties are hereby incorporated by reference into this application in order to more fully describe the state of the art to which this invention pertains.
[00023] The invention has been described in an illustrative manner, and it is to be understood that the terminology, which has been used is intended to be in the nature of words of description rather than of limitation.
[00024] Obviously, many modifications and variations of the present invention are possible in light of the above teachings. It is, therefore, to be understood that within the scope of the appended claims, the invention can be practiced otherwise than as specifically described.

Claims

CLAIMS What is claimed is:
1. A face mask comprising a body and at least one securing mechanism operatively attached to said body, and a used indicator mechanism for indicating that said face mask is used and an infectious disease detection mechanism for indicating if a user wearing said face mask has an infectious disease operatively integrated into said body.
2. The face mask of claim 1 , wherein said body is made of a material chosen from the group consisting of cloth, cotton, nylon, and filter material.
3. The face mask of claim 1 , wherein said body is a size chosen from the group consisting of child sized and adult sized.
4. The face mask of claim 1 , wherein said body further includes a pocket for filters.
5. The face mask of claim 1 , wherein said securing mechanism is chosen from the group consisting of elastic ear loops, ties, and combinations thereof.
6. The face mask of claim 1 , wherein said used indicator mechanism omits an odor after a predetermined time of use of said face mask.
7. The face mask of claim 1 , wherein said used indicator mechanism is further defined as a color change mechanism for changing said body from a first unused color to a second used color.
8. The face mask of claim 7, wherein said first unused color is chosen from the group consisting of red, orange, yellow, green, blue, purple, grey, black, and white and wherein said second used color is chosen from the group consisting of red, orange, yellow, green, blue, purple, grey, black, and white.
9. The face mask of claim 1 , wherein said used indicator mechanism is activated by a method chosen from the group consisting of passive activation and active activation.
6
10. The face mask of claim 1 , wherein said used indicator mechanism is integrated into an entirety of said body or a portion of said body.
11 . The face mask of claim 1 , wherein said infectious disease detection mechanism includes a mechanism chosen from the group consisting of antibody detection, DNA detection, RNA detection, and protein detection.
12. The face mask of claim 1 , wherein said infectious disease detection mechanism includes a color change mechanism wherein said body changes from a first color indicating no disease to a second color indicating presence of disease.
13. The face mask of claim 12, wherein said color change mechanism is a different color than said used indicator mechanism.
14. The face mask of claim 12, wherein said infectious disease detection mechanism is activated by a method chosen from the group consisting of passive activation and active activation.
15. The face mask of claim 12, wherein said infectious disease detection mechanism is integrated into an entirety of said body or a portion of said body.
16. The face mask of claim 12, wherein said infectious disease detection mechanism indicates said user’s disease status in real time.
17. The face mask of claim 12, wherein said infectious disease detection mechanism is located at a part of said body chosen from the group consisting of an outer surface, an inner surface, an outer surface and an inner surface, and integrated on a disposable filter insert inside a pocket in said body.
18. The face mask of claim 1 , wherein the infectious disease is chosen from the group consisting of influenza, measles, COVID-19, AIDS, amebiasis, anaplasmosis, anthrax, antibiotic resistance, avian influenza, babesiosis, botulism, brucellosis, Campylobacter, cat
7 scratch disease, chickenpox, chikungunya, chlamydia trachomatis, cholera, Clostridium perfringens, conjunctivitis, crusted scabies, cryptosporidiosis, cyclospora, dengue fever, diphtheria, ebola virus disease, E. coli, eastern equine encephalitis (EEE), enterovirus 68, fifth disease, genital herpes, genital warts, giardia, gonorrhea, group A Streptococcus, Guillain- Barre syndrome, Hand, Foot & Mouth Disease, Hansen's disease, hantavirus, lice, hepatitis A, hepatitis B, hepatitis C, herpes, herpes B virus, Hib disease, histoplasmosis, HIV, HPV (Human Papillomavirus), impetigo, Kawasaki syndrome, legionellosis, leprosy, leptospirosis, listeriosis, lyme disease, lymphocytic choriomeningitis (LCMV), malaria, Marburg virus, meningitis, meningococcal disease, MERS (Middle East Respiratory Illness), monkeypox, mononucleosis, MRSA, mumps, mycoplasma pneumoniae, neisseria meningitis, norovirus, Orf Virus (Sore Mouth), pelvic inflammatory disease (PID), PEP, pertussis, pink eye, plague, pneumococcal disease, powassan virus, psittacosis, Q fever, rabies, raccoon roundworm, rat bite fever, Reye’s Syndrome, Rickettsialpox, ringworm, rubella, salmonella, scabies, scarlet fever, shigella, shingles, smallpox, strep throat, syphilis, tetanus, toxoplasmosis, trichinosis, trichomoniasis, tuberculosis, tularemia, varicella, vibriosis, viral hemorrhagic fevers (VHF), West Nile virus, whooping cough, yellow fever, yersiniosis, and zika virus.
19. A method of indicating whether a face mask is used, including the steps of: a user actuating a used indicator mechanism on a face mask; wearing the face mask; and the used indicator mechanism indicating that the face mask is used.
20. The method of claim 19, wherein said indicating step is further defined as the used indicator mechanism performing a step chosen from the group consisting of emitting an odor, the used indicator mechanism changing a body of the face mask from a first color to a second color, and combinations thereof.
8
21 . The method of claim 19, wherein said actuating step is further defined as a step chosen from the group consisting of the user putting on the face mask, the user coughing into the face mask, clicking an actuator on the face mask, opening packaging containing the face mask, and peeling off a layer protecting the used indicator mechanism.
22. A method of indicating whether a user has an infectious disease, including the steps of: a user actuating an infectious disease mechanism on a face mask; wearing the face mask; and the infectious disease mechanism indicating that the user has an infectious disease by changing from a first color to a second color.
23. The method of claim 22, wherein said actuating step is further defined as a step chosen from the group consisting of the user putting on the face mask, the user coughing into the face mask, clicking an actuator on the face mask, opening packaging containing the face mask, and peeling off a layer protecting the infectious disease mechanism.
24. The method of claim 22, wherein the infectious disease is chosen from the group consisting of influenza, measles, COVID-19, AIDS, amebiasis, anaplasmosis, anthrax, antibiotic resistance, avian influenza, babesiosis, botulism, brucellosis, Campylobacter, cat scratch disease, chickenpox, chikungunya, chlamydia trachomatis, cholera, Clostridium perfringens, conjunctivitis, crusted scabies, cryptosporidiosis, cyclospora, dengue fever, diphtheria, ebola virus disease, E. coli, eastern equine encephalitis (EEE), enterovirus 68, fifth disease, genital herpes, genital warts, giardia, gonorrhea, group A Streptococcus, Guillain- Barre syndrome, Hand, Foot & Mouth Disease, Hansen's disease, hantavirus, lice, hepatitis A, hepatitis B, hepatitis C, herpes, herpes B virus, Hib disease, histoplasmosis, HIV, HPV (Human Papillomavirus), impetigo, Kawasaki syndrome, legionellosis, leprosy, leptospirosis, listeriosis, lyme disease, lymphocytic choriomeningitis (LCMV), malaria, Marburg virus,
9 meningitis, meningococcal disease, MERS (Middle East Respiratory Illness), monkeypox, mononucleosis, MRSA, mumps, mycoplasma pneumoniae, neisseria meningitis, norovirus, Orf Virus (Sore Mouth), pelvic inflammatory disease (PID), PEP, pertussis, pink eye, plague, pneumococcal disease, powassan virus, psittacosis, Q fever, rabies, raccoon roundworm, rat bite fever, Reye’s Syndrome, Rickettsialpox, ringworm, rubella, salmonella, scabies, scarlet fever, shigella, shingles, smallpox, strep throat, syphilis, tetanus, toxoplasmosis, trichinosis, trichomoniasis, tuberculosis, tularemia, varicella, vibriosis, viral hemorrhagic fevers (VHF), West Nile virus, whooping cough, yellow fever, yersiniosis, and zika virus.
10
PCT/US2021/046079 2020-08-14 2021-08-16 Virus/biohazard indicating disposable face mask WO2022036303A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063065522P 2020-08-14 2020-08-14
US63/065,522 2020-08-14

Publications (1)

Publication Number Publication Date
WO2022036303A1 true WO2022036303A1 (en) 2022-02-17

Family

ID=80246657

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2021/046079 WO2022036303A1 (en) 2020-08-14 2021-08-16 Virus/biohazard indicating disposable face mask

Country Status (1)

Country Link
WO (1) WO2022036303A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220295912A1 (en) * 2021-03-16 2022-09-22 Cherackal Chacko Smart Mask
DE102021005160A1 (en) 2021-10-15 2023-04-20 Guido Maiworm-Kamphausen Respirator mask detects flu infection or influenza virus
WO2023137310A1 (en) * 2022-01-17 2023-07-20 Taylor Keith H Virus/biohazard indicating disposable face mask
CN116627027A (en) * 2023-07-19 2023-08-22 济南大学 Optimal robustness control method based on improved PID

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070199567A1 (en) * 2006-01-25 2007-08-30 Kanzer Steve H Droplet collection devices and methods to detect and control airborne communicable diseases utilizing rfid
US20080092909A1 (en) * 2004-09-20 2008-04-24 California Pacific Medical Center Face Mask
WO2015166444A1 (en) * 2014-05-01 2015-11-05 University Of Cape Town Method and device to monitor infectious patients
US20160015098A1 (en) * 2013-03-15 2016-01-21 Matthew CONLON A facemask having one or more nanofiber layers
US20180368492A1 (en) * 2015-11-13 2018-12-27 Rocky Qu Perfumed dust mask
US20190125011A1 (en) * 2016-04-12 2019-05-02 Thomas Jefferson University Temperature sensitive surgical face mask for identifying at risk patients and reducing viral infection

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080092909A1 (en) * 2004-09-20 2008-04-24 California Pacific Medical Center Face Mask
US20070199567A1 (en) * 2006-01-25 2007-08-30 Kanzer Steve H Droplet collection devices and methods to detect and control airborne communicable diseases utilizing rfid
US20160015098A1 (en) * 2013-03-15 2016-01-21 Matthew CONLON A facemask having one or more nanofiber layers
WO2015166444A1 (en) * 2014-05-01 2015-11-05 University Of Cape Town Method and device to monitor infectious patients
US20180368492A1 (en) * 2015-11-13 2018-12-27 Rocky Qu Perfumed dust mask
US20190125011A1 (en) * 2016-04-12 2019-05-02 Thomas Jefferson University Temperature sensitive surgical face mask for identifying at risk patients and reducing viral infection

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220295912A1 (en) * 2021-03-16 2022-09-22 Cherackal Chacko Smart Mask
US11622586B2 (en) * 2021-03-16 2023-04-11 Cherackal Chacko Patient face mask for identifying vaccination status and controlling movement within a medical facility
DE102021005160A1 (en) 2021-10-15 2023-04-20 Guido Maiworm-Kamphausen Respirator mask detects flu infection or influenza virus
WO2023137310A1 (en) * 2022-01-17 2023-07-20 Taylor Keith H Virus/biohazard indicating disposable face mask
CN116627027A (en) * 2023-07-19 2023-08-22 济南大学 Optimal robustness control method based on improved PID
CN116627027B (en) * 2023-07-19 2024-01-30 济南大学 Optimal robustness control method based on improved PID

Similar Documents

Publication Publication Date Title
WO2022036303A1 (en) Virus/biohazard indicating disposable face mask
Puro et al. Risk of hepatitis C seroconversion after occupational exposures in health care workers
Holzmann et al. Eradication of measles: remaining challenges
Poland et al. Evaluation of the potency and safety of inactivated Japanese encephalitis vaccine in US inhabitants
Reingold et al. Failure of gloves and other protective devices to prevent transmission of hepatitis B virus to oral surgeons
Jayanth et al. Needle stick injuries in a tertiary care hospital
Teperman et al. West Nile Virus Infections in Organ Transplant Recipients--New York and Pennsylvania, August--September, 2005.
Peterman et al. Estimating the risks of transfusion‐associated acquired immune deficiency syndrome and human immunodeficiency virus infection
Garmendia et al. The West Nile virus: its recent emergence in North America
Bowen et al. Clinical aspects of human Venezuelan equine encephalitis in Texas
Mast et al. Prevention of hepatitis B virus infection among health-care workers
Petersen et al. Human rabies epidemiology and diagnosis
Black Epidemiology of paramyxoviridae
Ligon Outbreak of Marburg hemorrhagic fever in Angola: a review of the history of the disease and its biological aspects
Curran et al. Australia’s notifiable diseases status, 1996
Tu et al. Prevalence and incidence of hepatitis C virus in hemodialysis patients in British Columbia: follow‐up after a possible breach in hemodialysis machines
WO2023137310A1 (en) Virus/biohazard indicating disposable face mask
Nelson Epidemiology of infectious disease: general principles
Abrahamian et al. Rhabdovirus: rabies
Alter et al. Immunization of health-care workers: recommendations of the advisory committee on immunization practices (ACIP) and the hospital infection control practices advisory committee (HICPAC)
Kristiansen TBE in Denmark-in particular on Bornholm
Younai Postexposure protocol
De la Tejera Hernández et al. Analysis of risk factors associated to cytomegalovirus infection in dentistry students
Ertem et al. Poliomyelitis eradication programme: acute flaccid paralysis surveillance in Mardin and five other provinces around Mardin, Turkey 1998
Jun Date of Onset

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21856845

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21856845

Country of ref document: EP

Kind code of ref document: A1